Antimicrobial Resistance Patterns of Staphylococcus Aureus Isolated at a General Hospital in Vietnam Between 2014 and 2021

References

• Antimicrobial Resistance C, Ikuta KS, Sharara F. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629–655. doi:10.1016/S0140-6736(21)02724-0
   PubMed Web of Science ®Google Scholar
• Dayan GH, Mohamed N, Scully IL, et al. Staphylococcus aureus: the current state of disease, pathophysiology and strategies for prevention. Expert Rev Vaccines. 2016;15(11):1373–1392. doi:10.1080/14760584.2016.1179583
   PubMed Web of Science ®Google Scholar
• European Antimicrobial Resistance C. The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis. Lancet Public Health. 2022;7(11):e897–e913. doi:10.1016/S2468-2667(22)00225-0
   PubMed Web of Science ®Google Scholar
• Haque M, Sartelli M, McKimm J, Abu Bakar M. Health care-associated infections - an overview. Infect Drug Resist. 2018;11:2321–2333. doi:10.2147/IDR.S177247
   PubMed Web of Science ®Google Scholar
• Tadesse S, Alemayehu H, Tenna A, et al. Antimicrobial resistance profile of Staphylococcus aureus isolated from patients with infection at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia. BMC Pharmacol Toxicol. 2018;19(1):24. doi:10.1186/s40360-018-0210-9
   PubMed Web of Science ®Google Scholar
• Kot B, Wierzchowska K, Piechota M, Gruzewska A. Antimicrobial Resistance Patterns in Methicillin-Resistant Staphylococcus aureus from Patients Hospitalized during 2015–2017 in Hospitals in Poland. Med Princ Pract. 2020;29(1):61–68. doi:10.1159/000501788
   PubMed Web of Science ®Google Scholar
• Liu C, Yoon EJ, Kim D, et al. Antimicrobial resistance in South Korea: a report from the Korean global antimicrobial resistance surveillance system (Kor-GLASS) for 2017. J Infect Chemother. 2019;25(11):845–859. doi:10.1016/j.jiac.2019.06.010
   PubMed Web of Science ®Google Scholar
• Choisy M. Antimicrobial susceptibility testing results from 13 hospitals in Viet Nam: VINARES 2016–2017. Antimicrob Resist Infect Control. 2021;10(1):78. doi:10.1186/s13756-021-00937-4
   PubMed Web of Science ®Google Scholar
• World Health Organization. Antimicrobial resistance in Vietnam. https://www.who.int/vietnam/health-topics/antimicrobial-resistance. Acessed 22 January, 2024.
   Google Scholar
• Leber AL. Clinical Microbiology Procedures Handbook. 4th ed. Washington, D.C: American Society for Microbiology; 2016.
   Google Scholar
• Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing, M100-S24. 24th ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2014.
   Google Scholar
• Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing, M100-S25. 25th ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2015.
   Google Scholar
• Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing, M100-S26. 26th ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2016.
   Google Scholar
• Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing, M100-S27. 27th ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2017.
   Google Scholar
• Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing, M100-S28. 28th ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2018.
   Google Scholar
• Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing, M100-S29. 29th ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2019.
   Google Scholar
• Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing, M100-S30. 30th ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2020.
   Google Scholar
• Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing, M100-S31. 31st ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2021.
   Google Scholar
• Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. doi:10.1111/j.1469-0691.2011.03570.x
   PubMed Web of Science ®Google Scholar
• Lee H, Yoon EJ, Kim D, et al. Antimicrobial resistance of major clinical pathogens in South Korea, May 2016 to April 2017: first one-year report from Kor-GLASS. Euro Surveill. 2018;23:1.
   Google Scholar
• Hu F, Guo Y, Yang Y, et al. Resistance reported from China antimicrobial surveillance network (CHINET) in 2018. Eur J Clin Microbiol Infect Dis. 2019;38(12):2275–2281. doi:10.1007/s10096-019-03673-1
   PubMed Web of Science ®Google Scholar
• Diekema DJ, Pfaller MA, Shortridge D, Zervos M, Jones RN. Twenty-year trends in antimicrobial susceptibilities among staphylococcus aureus from the SENTRY antimicrobial surveillance program. Open Forum Infect Dis. 2019;6(Suppl 1):S47–S53. doi:10.1093/ofid/ofy270
   PubMed Web of Science ®Google Scholar
• Mhondoro M, Ndlovu N, Bangure D, et al. Trends in antimicrobial resistance of bacterial pathogens in Harare, Zimbabwe, 2012–2017: a secondary dataset analysis. BMC Infect Dis. 2019;19(1):746. doi:10.1186/s12879-019-4295-6
   PubMed Web of Science ®Google Scholar
• Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev. 1997;10(3):505–520. doi:10.1128/CMR.10.3.505
   PubMed Web of Science ®Google Scholar
• Waitayangkoon P, Thongkam A, Benjamungkalarak T, et al. Hospital epidemiology and antimicrobial susceptibility of isolated methicillin-resistant Staphylococcus aureus: a one-year retrospective study at a tertiary care center in Thailand. Pathog Glob Health. 2020;114(4):212–217. doi:10.1080/20477724.2020.1755550
   PubMed Web of Science ®Google Scholar
• Gitau W, Masika M, Musyoki M, Museve B, Mutwiri T. Antimicrobial susceptibility pattern of Staphylococcus aureus isolates from clinical specimens at Kenyatta National Hospital. BMC Res Notes. 2018;11(1):226. doi:10.1186/s13104-018-3337-2
   PubMedGoogle Scholar
• Wood JB, Smith DB, Baker EH, Brecher SM, Gupta K. Has the emergence of community-associated methicillin-resistant Staphylococcus aureus increased trimethoprim-sulfamethoxazole use and resistance?: a 10-year time series analysis. Antimicrob Agents Chemother. 2012;56(11):5655–5660. doi:10.1128/AAC.01011-12
   PubMed Web of Science ®Google Scholar
• Nurjadi D, Olalekan AO, Layer F, et al. Emergence of trimethoprim resistance gene dfrG in Staphylococcus aureus causing human infection and colonization in sub-Saharan Africa and its import to Europe. J Antimicrob Chemother. 2014;69(9):2361–2368. doi:10.1093/jac/dku174
   PubMed Web of Science ®Google Scholar
• Coelho C, de Lencastre H, Aires-de-Sousa M. Frequent occurrence of trimethoprim-sulfamethoxazole hetero-resistant Staphylococcus aureus isolates in different African countries. Eur J Clin Microbiol Infect Dis. 2017;36(7):1243–1252. doi:10.1007/s10096-017-2915-x
   PubMed Web of Science ®Google Scholar
• El Mekes A, Zahlane K, Ait Said L, Tadlaoui Ouafi A, Barakate M. The clinical and epidemiological risk factors of infections due to multi-drug resistant bacteria in an adult intensive care unit of University Hospital Center in Marrakesh-Morocco. J Infect Public Health. 2020;13(4):637–643. doi:10.1016/j.jiph.2019.08.012
   PubMed Web of Science ®Google Scholar
• Timsit JF, Bassetti M, Cremer O, et al. Rationalizing antimicrobial therapy in the ICU: a narrative review. Intensive Care Med. 2019;45(2):172–189. doi:10.1007/s00134-019-05520-5
   PubMed Web of Science ®Google Scholar
• Styers D, Sheehan DJ, Hogan P, Sahm DF. Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States. Ann Clin Microbiol Antimicrob. 2006;5:2. doi:10.1186/1476-0711-5-2
   PubMedGoogle Scholar
• Samadi R, Ghalavand Z, Mirnejad R, Nikmanesh B, Eslami G. Antimicrobial resistance and molecular characteristics of methicillin-resistant staphylococcus aureus isolates from children patients in Iran. Infect Drug Resist. 2019;12:3849–3857. doi:10.2147/IDR.S229394
   PubMed Web of Science ®Google Scholar
• Senobar Tahaei SA, Stajer A, Barrak I, Ostorhazi E, Szabo D, Gajdacs M. Correlation between biofilm-formation and the antibiotic resistant phenotype in staphylococcus aureus isolates: a laboratory-based study in Hungary and a review of the literature. Infect Drug Resist. 2021;14:1155–1168. doi:10.2147/IDR.S303992
   PubMed Web of Science ®Google Scholar
• Yu F, Yang L, Pan J, et al. Prevalence of virulence genes among invasive and colonising Staphylococcus aureus isolates. J Hosp Infect. 2011;77(1):89–91. doi:10.1016/j.jhin.2010.07.019
   PubMed Web of Science ®Google Scholar
• Mazloomirad F, Hasanzadeh S, Sharifi A, Nikbakht G, Roustaei N, Khoramrooz SS. Identification and detection of pathogenic bacteria from patients with hospital-acquired pneumonia in southwestern Iran; evaluation of biofilm production and molecular typing of bacterial isolates. BMC Pulm Med. 2021;21(1):408. doi:10.1186/s12890-021-01773-3
   PubMed Web of Science ®Google Scholar
• Manandhar S, Singh A, Varma A, Pandey S, Shrivastava N. Biofilm producing clinical staphylococcus aureus isolates augmented prevalence of antibiotic resistant cases in tertiary care hospitals of Nepal. Front Microbiol. 2018;9:2749. doi:10.3389/fmicb.2018.02749
   PubMed Web of Science ®Google Scholar
• Mottola C, Matias CS, Mendes JJ, et al. Susceptibility patterns of Staphylococcus aureus biofilms in diabetic foot infections. BMC Microbiol. 2016;16(1):119. doi:10.1186/s12866-016-0737-0
   PubMedGoogle Scholar
• Moormeier DE, Endres JL, Mann EE, et al. Use of microfluidic technology to analyze gene expression during Staphylococcus aureus biofilm formation reveals distinct physiological niches. Appl Environ Microbiol. 2013;79(11):3413–3424. doi:10.1128/AEM.00395-13
   PubMed Web of Science ®Google Scholar
• Costa SS, Viveiros M, Amaral L, Couto I. Multidrug Efflux Pumps in Staphylococcus aureus: an Update. Open Microbiol J. 2013;7:59–71. doi:10.2174/1874285801307010059
   PubMedGoogle Scholar
• Haaber J, Penades JR, Ingmer H. Transfer of Antibiotic Resistance in Staphylococcus aureus. Trends Microbiol. 2017;25(11):893–905. doi:10.1016/j.tim.2017.05.011
   PubMed Web of Science ®Google Scholar
• Karakonstantis S, Kalemaki D. Antimicrobial overuse and misuse in the community in Greece and link to antimicrobial resistance using methicillin-resistant S. aureus as an example. J Infect Public Health. 2019;12(4):460–464. doi:10.1016/j.jiph.2019.03.017
   PubMed Web of Science ®Google Scholar
• Zhen X, Stalsby Lundborg C, Sun X, Zhu N, Gu S, Dong H. Economic burden of antibiotic resistance in China: a national level estimate for inpatients. Antimicrob Resist Infect Control. 2021;10(1):5. doi:10.1186/s13756-020-00872-w
   PubMed Web of Science ®Google Scholar
• Dilnessa T, Bitew A. Prevalence and antimicrobial susceptibility pattern of methicillin resistant Staphylococcus aureus isolated from clinical samples at Yekatit 12 Hospital Medical College, Addis Ababa, Ethiopia. BMC Infect Dis. 2016;16:398. doi:10.1186/s12879-016-1742-5
   PubMed Web of Science ®Google Scholar
• Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis. 2003;36(1):53–59. doi:10.1086/345476
   PubMed Web of Science ®Google Scholar
• Uematsu H, Yamashita K, Kunisawa S, Fushimi K, Imanaka Y. Estimating the disease burden of methicillin-resistant Staphylococcus aureus in Japan: retrospective database study of Japanese hospitals. PLoS One. 2017;12(6):e0179767. doi:10.1371/journal.pone.0179767
   PubMed Web of Science ®Google Scholar
• Inagaki K, Lucar J, Blackshear C, Hobbs CV. Methicillin-susceptible and methicillin-resistant staphylococcus aureus bacteremia: nationwide estimates of 30-day readmission, in-hospital mortality, length of stay, and cost in the United States. Clin Infect Dis. 2019;69(12):2112–2118. doi:10.1093/cid/ciz123
   PubMed Web of Science ®Google Scholar
• Zhen X, Lundborg CS, Zhang M, et al. Clinical and economic impact of methicillin-resistant Staphylococcus aureus: a multicentre study in China. Sci Rep. 2020;10(1):3900. doi:10.1038/s41598-020-60825-6
   PubMed Web of Science ®Google Scholar
• Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52(3):e18–55. doi:10.1093/cid/ciq146
   PubMed Web of Science ®Google Scholar
• Casapao AM, Leonard SN, Davis SL, et al. Clinical outcomes in patients with heterogeneous vancomycin-intermediate staphylococcus aureus bloodstream infection. Antimicrob Agents Chemother. 2013;57(9):4252–4259. doi:10.1128/AAC.00380-13
   PubMed Web of Science ®Google Scholar
• Shariati A, Dadashi M, Moghadam MT, van Belkum A, Yaslianifard S, Darban-Sarokhalil D. Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis. Sci Rep. 2020;10(1):12689. doi:10.1038/s41598-020-69058-z
   PubMed Web of Science ®Google Scholar
• Guffey AA, Loll PJ. Regulation of resistance in vancomycin-resistant enterococci: the vanrs two-component system. Microorganisms. 2021;9:3
   Web of Science ®Google Scholar
• Lee AS, de Lencastre H, Garau J, et al. Methicillin-resistant Staphylococcus aureus. Nat Rev Dis Primers. 2018;4:18033. doi:10.1038/nrdp.2018.33
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global Priority List of Antibiotic-Resistant Bacteria to Guide Research, Discovery, and Development of New Antibiotics. Secondary Global Priority List of Antibiotic-Resistant Bacteria to Guide Research, Discovery, and Development of New Antibiotics. World Health Organization; 2017.
   Google Scholar